Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 1Metabolic Syndrome 1Inflammation 1Dyslipidemias 1

Interventions

Surveys and Questionnaires 9Blood Specimen Collection 5naloxegol 3Therapeutics 3Observation 3Interviews as Topic 3Bariatric Surgery 3naldemedine 2exemestane 2Tirzepatide 2Tamoxifen 2Psychiatric Rehabilitation 2Paclitaxel 2Hematologic Tests 2Esophagectomy 2Echocardiography 2Carboplatin 2Biopsy 2BaseLine dental cement 2Anastrozole 2trametinib 1sotorasib 1semaglutide 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × semaglutide × Other × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡